Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling

Molecular Pharmacology

Volumn 79, Issue 4, 2011, Pages 768-775

  Feng, Bo ^a   Li, Zhihua ^b   Wang, Jia Bei ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; PHORBOL MYRISTATE; PROTEIN KINASE C; SERINE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHINESE HAMSTER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; FEMALE; IN VITRO STUDY; LIGAND BINDING; MASS SPECTROMETRY; MUTAGENESIS; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ISOENZYMES; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 79953003015     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.069096     Document Type: Article

References (38)

1. Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, and Henderson G (2009) Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci 29:307-318.
2. Battaini F (2001) Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol Res 44:353-361.
3. Bernstein MA and Welch SP (1998) mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance. Brain Res Mol Brain Res 55:237-242. (Pubitemid 28248040)
4. Breitwieser GE (2005) GIRK channels: hierarchy of control. Focus on "PKC-delta sensitizes Kir3.1/3.2 channels to changes in membrane phospholipid levels after M3 receptor activation in HEK-293 cells". Am J Physiol Cell Physiol 289:C509-C511.
5. Burd AL, El-Kouhen R, Erickson LJ, Loh HH, and Law PY (1998) Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor. J Biol Chem 273:34488-34495. (Pubitemid 29008929)
6. Celver JP, Lowe J, Kovoor A, Gurevich VV, and Chavkin C (2001) Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes. J Biol Chem 276:4894-4900.
7. Chakrabarti S and Gintzler AR (2003) Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity. Brain Res Mol Brain Res 119:144-151. (Pubitemid 37415087)
8. Deng HB, Yu Y, Pak Y, O'Dowd BF, George SR, Surratt CK, Uhl GR, and Wang JB (2000) Role for the C-terminus in agonist-induced mu opioid receptor phosphorylation and desensitization. Biochemistry 39:5492-5499. (Pubitemid 30257091)
9. El Kouhen R, Burd AL, Erickson-Herbrandson LJ, Chang CY, Law PY, and Loh HH (2001) Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. J Biol Chem 276:12774-12780.
10. Ferguson SS, Zhang J, Barak LS, and Caron MG (1998) Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci 62:1561-1565. (Pubitemid 28210241)
11. Granados-Soto V, Kalcheva I, Hua X, Newton A, and Yaksh TL (2000) Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain 85:395-404. (Pubitemid 30214166)
12. Gurevich VV and Gurevich EV (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther 110:465-502.
13. Haller VL, Bernstein MA, and Welch SP (2008) Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel. Eur J Pharmacol 578:101-107. (Pubitemid 350309572)
14. Harrison LM, Kastin AJ, and Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides 19:1603-1630. (Pubitemid 29015903)
15. Key TA, Foutz TD, Gurevich VV, Sklar LA, and Prossnitz ER (2003) N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity. J Biol Chem 278:4041-4047. (Pubitemid 36801138)
16. King AP, Hall KE, and Macdonald RL (1999) Kappa- and mu-opioid inhibition of N-type calcium currents is attenuated by 4beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 289:312-320. (Pubitemid 29156044)
17. Koch T, Kroslak T, Mayer P, Raulf E, and Höllt V (1997) Site mutation in the rat mu-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J Neurochem 69:1767-1770. (Pubitemid 27406979)
18. Koch T, Schulz S, Schröder H, Wolf R, Raulf E, and Höllt V (1998) Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 273:13652-13657. (Pubitemid 28268410)
19. Kovoor A, Nappey V, Kieffer BL, and Chavkin C (1997) Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes. J Biol Chem 272:27605-27611. (Pubitemid 27473552)
20. Kramer HK and Simon EJ (1999a) Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. J Neurochem 72:585-593. (Pubitemid 29055220)
21. Kramer HK and Simon EJ (1999b) Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. J Neurochem 72:594-604. (Pubitemid 29055221)
22. Law PY and Loh HH (1999) Regulation of opioid receptor activities. J Pharmacol Exp Ther 289:607-624.
23. Lin TH, Lai HL, Kao YY, Sun CN, Hwang MJ, and Chern Y (2002) Protein kinase C inhibits type VI adenylyl cyclase by phosphorylating the regulatory N domain and two catalytic C1 and C2 domains. J Biol Chem 277:15721-15728.
24. Mandyam CD, Thakker DR, Christensen JL, and Standifer KM (2002) Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther 302:502-509. (Pubitemid 34787212)
25. Mellor H and Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332:281-292. (Pubitemid 28271856)
26. Oldfield S, Braksator E, Rodriguez-Martin I, Bailey CP, Donaldson LF, Henderson G, and Kelly E (2008) C-terminal splice variants of the mu-opioid receptor: existence, distribution and functional characteristics. J Neurochem 104:937-945. (Pubitemid 351143648)
27. Pak Y, O'Dowd BF, and George SR (1997) Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J Biol Chem 272:24961-24965. (Pubitemid 27415673)
28. Pan YX, Xu J, Bolan E, Abbadie C, Chang A, Zuckerman A, Rossi G, and Pasternak GW (1999) Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol Pharmacol 56:396-403. (Pubitemid 29347617)
29. Pasternak GW (2004) Multiple opiate receptors: déjà vu all over again. Neuropharmacology 47:312-323.
30. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, and Höllt V (2004) Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23:3282-3289. (Pubitemid 39209152)
31. Ueda H, Inoue M, and Matsumoto T (2001) Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J Neurosci 21:2967-2973. (Pubitemid 32323477)
32. Vishnivetskiy SA, Raman D, Wei J, Kennedy MJ, Hurley JB, and Gurevich VV (2007) Regulation of arrestin binding by rhodopsin phosphorylation level. J Biol Chem 282:32075-32083. (Pubitemid 350106464)
33. Wang HL, Chang WT, Hsu CY, Huang PC, Chow YW, and Li AH (2002) Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors. Biochem Pharmacol 64:257-266.
34. Wang L, Medina VM, Rivera M, and Gintzler AR (1996) Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue. Brain Res 723:61-69. (Pubitemid 26200127)
35. Wolf R, Koch T, Schulz S, Klutzny M, Schröder H, Raulf E, Bühling F, and Höllt V (1999) Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor. Mol Pharmacol 55:263-268. (Pubitemid 29076022)
36. Yu Y, Zhang L, Yin X, Sun H, Uhl GR, and Wang JB (1997) Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272:28869-28874. (Pubitemid 27498167)
37. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162. (Pubitemid 28278123)
38. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, and Wang JB (1996) Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271:11449-11454. (Pubitemid 26155986)